SCHEMBL9035200

SCHEMBL9035200

O=C1C[C@@H](CO)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6976367 1.00
SCHEMBL6976364 1.00
SCHEMBL9184177 0.79
SCHEMBL9661583 0.79
SCHEMBL289406 0.75 CRBN (0.41)
SCHEMBL4905898 0.74 CREBBP (1.00)
SCHEMBL14258530 0.74 CREBBP (1.00)
SCHEMBL4907033 0.74 CREBBP (1.00)
SCHEMBL16611889 0.74
SCHEMBL5768296 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001564-B2 Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2021-05-11 US disclosed
US-20190225593-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2019-07-25 US disclosed
WO-2018052967-A1 SUBSTITUTED CHROMANE-8-CARBOXAMIDE COMPOUNDS AND ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2018-03-22 WO disclosed
EP-2646436-B1 MONOBACTAMS PFIZER (US) 2015-05-27 EP disclosed
US-7943605-B2 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses UCB PHARMA S.A. (BE) 2011-05-17 US disclosed
US-7943605-B2 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses UCB PHARMA S.A. (BE) 2011-05-17 US disclosed
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 US disclosed
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 US disclosed
WO-2007048595-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA, S.A. (BE) 2007-05-03 WO disclosed
EP-0362902-B1 Process and intermediates for beta-lactam antibiotics HARVARD COLLEGE (US) 1996-01-17 EP disclosed
US-4378315-A Process for the preparation of thienamycin and intermediates MERCK & CO., INC. (US) 1983-03-29 US disclosed
EP-0066301-A1 Intermediates for the preparation of thienamycin and process for preparing the same MERCK & CO. INC. (US) 1982-12-08 EP disclosed
US-4309346-A INTERMEDIATES FOR AMINO ACID DERIVATIVE ANTIBIOTICS MERCK & CO., INC. (US) 1982-01-05 US disclosed
EP-0037082-A1 Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals MERCK & CO. INC. (US) 1981-10-07 EP disclosed
EP-0037081-A1 Process for the preparation of 1-carbapenems and intermediates via trithioorthoacetates MERCK & CO. INC. (US) 1981-10-07 EP disclosed
US-4290947-A Process for the preparation of thienamycin and intermediates MERCK & CO., INC. (US) 1981-09-22 US disclosed
US-4275207-A Process for preparing 7-(1-hydroxyethyl)-3-(2-aminoethylthio)-1-carbadethiaceph-3-em-3-carboxylic acid and intermediate therefor MERCK & CO., INC. (US) 1981-06-23 US disclosed
EP-0026816-A1 Intermediates for the preparation of thienamycin and process for preparing intermediates MERCK & CO. INC. (US) 1981-04-15 EP disclosed
EP-0007973-A1 Process for the preparation of thienamycin and intermediates MERCK & CO. INC. (US) 1980-02-20 EP disclosed
US-4174316-A 4-Iodomethylazetidin-2-one MERCK & CO., INC. (US) 1979-11-13 US disclosed